NO960629D0 - (Ikke-peptid endothelin-antagonister I). Substituerte 2 (5H) furanon-,2 (5H) tiofenon- og 2 (5H) pyrrolonderivater, deres fremstilling og deres anvendelse som endetholin-antagonister - Google Patents
(Ikke-peptid endothelin-antagonister I). Substituerte 2 (5H) furanon-,2 (5H) tiofenon- og 2 (5H) pyrrolonderivater, deres fremstilling og deres anvendelse som endetholin-antagonisterInfo
- Publication number
- NO960629D0 NO960629D0 NO960629A NO960629A NO960629D0 NO 960629 D0 NO960629 D0 NO 960629D0 NO 960629 A NO960629 A NO 960629A NO 960629 A NO960629 A NO 960629A NO 960629 D0 NO960629 D0 NO 960629D0
- Authority
- NO
- Norway
- Prior art keywords
- antagonists
- endetholine
- thiophenone
- furanone
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
- C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
- C07C47/105—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing rings
- C07C47/11—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing rings monocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/235—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
- C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10975193A | 1993-08-19 | 1993-08-19 | |
US21757894A | 1994-03-24 | 1994-03-24 | |
US27888294A | 1994-07-26 | 1994-07-26 | |
PCT/US1994/009091 WO1995005376A1 (en) | 1993-08-19 | 1994-08-09 | Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
NO960629D0 true NO960629D0 (no) | 1996-02-16 |
NO960629L NO960629L (no) | 1996-02-16 |
Family
ID=27380718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO960629A NO960629L (no) | 1993-08-19 | 1996-02-16 | (Ikke-peptid endothelin-antagonister I). Substituerte 2 (5H) furanon-,2 (5H) tiofenon- og 2 (5H) pyrrolonderivater, deres fremstilling og deres anvendelse som endetholin-antagonister |
Country Status (13)
Country | Link |
---|---|
US (2) | US5691373A (no) |
EP (1) | EP0714391A1 (no) |
JP (1) | JPH09501920A (no) |
KR (1) | KR960703901A (no) |
AU (1) | AU693110B2 (no) |
CA (1) | CA2165567A1 (no) |
CZ (1) | CZ40996A3 (no) |
FI (1) | FI960671A (no) |
HU (1) | HUT74179A (no) |
NO (1) | NO960629L (no) |
NZ (1) | NZ271833A (no) |
SK (1) | SK20396A3 (no) |
WO (1) | WO1995005376A1 (no) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962490A (en) | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US6492413B2 (en) | 1993-01-15 | 2002-12-10 | G.D. Searle & Co. | 3.4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
US6376523B1 (en) | 1994-05-20 | 2002-04-23 | Texas Biotechnology Corporation | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
US6613804B2 (en) | 1993-05-20 | 2003-09-02 | Encysive Pharmaceuticals, Inc. | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
US6342610B2 (en) | 1993-05-20 | 2002-01-29 | Texas Biotechnology Corp. | N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US6541498B2 (en) | 1993-05-20 | 2003-04-01 | Texas Biotechnology | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
GB9602877D0 (en) * | 1996-02-13 | 1996-04-10 | Merck Frosst Canada Inc | 3,4-Diaryl-2-hydroxy-2,5- dihydrofurans as prodrugs to cox-2 inhibitors |
WO1995018799A1 (en) * | 1994-01-10 | 1995-07-13 | Merck Frosst Canada Inc. | Phenyl heterocycles as cox-2 inhibitors |
US6162927A (en) | 1994-08-19 | 2000-12-19 | Abbott Laboratories | Endothelin antagonists |
US7208517B1 (en) | 1994-08-19 | 2007-04-24 | Abbott Labortories | Endothelin antagonists |
US5767144A (en) * | 1994-08-19 | 1998-06-16 | Abbott Laboratories | Endothelin antagonists |
US5691374A (en) * | 1995-05-18 | 1997-11-25 | Merck Frosst Canada Inc. | Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors |
AU6388896A (en) * | 1995-07-06 | 1997-02-05 | Warner-Lambert Company | Butenolide endothelin antagonists |
US5922759A (en) * | 1996-06-21 | 1999-07-13 | Warner-Lambert Company | Butenolide endothelin antagonists |
US6017952A (en) * | 1995-08-02 | 2000-01-25 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
US5998468A (en) * | 1995-08-24 | 1999-12-07 | Warner-Lambert Company | Furanone endothelin antagonists |
US5981576A (en) * | 1995-10-13 | 1999-11-09 | Merck Frosst Canada, Inc. | (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors |
US6020343A (en) * | 1995-10-13 | 2000-02-01 | Merck Frosst Canada, Inc. | (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors |
US5977117A (en) | 1996-01-05 | 1999-11-02 | Texas Biotechnology Corporation | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
DE19607096A1 (de) * | 1996-02-24 | 1997-08-28 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
AU2077897A (en) * | 1996-04-10 | 1997-10-29 | Warner-Lambert Company | Nonpeptide endothelin antagonists with increased water solubility |
WO1997037987A1 (en) * | 1996-04-10 | 1997-10-16 | Warner-Lambert Company | Ketoacid endothelin antagonists |
US6133263A (en) * | 1996-04-10 | 2000-10-17 | Warner-Lambert Company | Endothelin antagonists with ether-linked groups |
US5804585A (en) | 1996-04-15 | 1998-09-08 | Texas Biotechnology Corporation | Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
GB9615867D0 (en) * | 1996-07-03 | 1996-09-11 | Merck & Co Inc | Process of preparing phenyl heterocycles useful as cox-2 inhibitors |
JP4125787B2 (ja) * | 1996-07-23 | 2008-07-30 | 塩野義製薬株式会社 | 新規ピリミジン化合物および医薬組成物 |
DE19653037A1 (de) * | 1996-12-19 | 1998-06-25 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
US6030975A (en) * | 1997-03-14 | 2000-02-29 | Basf Aktiengesellschaft | Carboxylic acid derivatives, their preparation and use in treating cancer |
DE19711428A1 (de) * | 1997-03-19 | 1998-09-24 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
TR200101905T2 (tr) | 1997-04-28 | 2002-06-21 | Texas Biotechnology Corporation | Endotelin ile ilgili hastalıkların tedavisinde kullanılan sülfanoamidler. |
US5783705A (en) | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
JP4058507B2 (ja) | 1997-07-10 | 2008-03-12 | 国立大学法人 東京医科歯科大学 | 4,5−ジヒドロ−[1H]−ベンズ[g]インダゾール−3−カルボン酸誘導体 |
DE19731571A1 (de) * | 1997-07-23 | 1999-01-28 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
US6080876A (en) * | 1997-10-29 | 2000-06-27 | Merck & Co., Inc. | Process for making phenyl heterocycles useful as COX-2 inhibitors |
AU3430699A (en) * | 1998-04-08 | 1999-11-01 | Washington Odur Ayuko | Butenolide derivatives as anti-cancer agents |
DE19818732A1 (de) * | 1998-04-27 | 1999-10-28 | Bayer Ag | Arylphenylsubstituierte cyclische Ketoenole |
JP3850596B2 (ja) | 1999-02-25 | 2006-11-29 | 本州化学工業株式会社 | 新規な部分保護トリスフェノール類とその製造方法 |
CN1093539C (zh) * | 1999-11-02 | 2002-10-30 | 中国科学院上海有机化学研究所 | 一种合成β一卤代丁烯酸内酯的方法 |
DK1533311T3 (da) | 1999-12-31 | 2007-09-17 | Encysive Pharmaceuticals Inc | Sulfonamider og derivater deraf, der modulerer aktiviteten af endothelin |
GB0003671D0 (en) * | 2000-02-17 | 2000-04-05 | Univ Cardiff | Diphenyl-substituted lower alkanes |
GB0007401D0 (en) * | 2000-03-27 | 2000-05-17 | Cancer Res Campaign Tech | Substituted chalcones as therapeeutic compounds |
BR0113610A (pt) * | 2000-08-31 | 2003-06-24 | Pfizer | Derivados da fenoxibenzilamina como inibidores seletivos de recuperação de serotonina |
US6610747B2 (en) | 2000-08-31 | 2003-08-26 | Pfizer Inc. | Phenoxybenzylamine derivatives as SSRIs |
US7101910B2 (en) * | 2001-06-12 | 2006-09-05 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
GB0123777D0 (en) | 2001-10-03 | 2001-11-21 | Cancer Res Ventures Ltd | Substituted chalcones as therapeutic agents |
GB0123780D0 (en) | 2001-10-03 | 2001-11-21 | Cancer Res Ventures Ltd | Substituted chalcones as therapeutic agents |
WO2004037171A2 (en) * | 2002-10-18 | 2004-05-06 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
CN1328271C (zh) * | 2005-06-21 | 2007-07-25 | 浙江大学 | 一种合成β-碘代丁烯酸内酯的方法 |
KR20080019243A (ko) * | 2005-06-24 | 2008-03-03 | 디에스엠 아이피 어셋츠 비.브이. | 비자가면역 제 2 형 진성당뇨병 및/또는 신드롬 x의치료용 화합물 |
WO2006136423A2 (en) * | 2005-06-24 | 2006-12-28 | Dsm Ip Assets B.V. | Medicament for the treatment of impaired glucose metabolism |
US7537774B2 (en) * | 2005-12-23 | 2009-05-26 | Orion Therapeautics, Llc | Therapeutic formulation |
KR20080111137A (ko) * | 2006-04-13 | 2008-12-22 | 액테리온 파마슈티칼 리미티드 | 초기 단계 특발성 폐 섬유증을 위한 엔도텔린 수용체 대항제 |
SI2641596T1 (sl) * | 2009-11-26 | 2018-09-28 | Genfit | Uporaba 1,3-difenilprop-2-en-1-on derivatov za zdravljenje motenj jeter |
US9221751B2 (en) | 2009-11-26 | 2015-12-29 | Genfit | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
US10722575B2 (en) | 2009-11-26 | 2020-07-28 | Genfit | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
FR3026607A1 (fr) * | 2014-10-03 | 2016-04-08 | Centre Nat Rech Scient | Composes permettant la conservation de cellules, tissus et organes, compositions et utilisations |
CN110963932B (zh) * | 2019-11-25 | 2021-06-04 | 中南大学 | 查尔酮衍生物及其制备方法和在抗弓形虫中的应用 |
CN111393421B (zh) * | 2020-04-07 | 2021-08-31 | 自然资源部第三海洋研究所 | 丁烯酸内酯类衍生物及其制备方法与应用 |
CN111925281B (zh) * | 2020-09-04 | 2022-04-15 | 江苏恩华药业股份有限公司 | 一种盐酸戊乙奎醚杂质2-环戊基-2-苯基乙醛的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ190995A (en) * | 1978-09-05 | 1982-03-09 | American Cyanamid Co | Substituted omega propionyl or butyryl l-prolines and pharmaceutical compositions |
JPS5916884A (ja) * | 1982-07-19 | 1984-01-28 | Fujisawa Pharmaceut Co Ltd | 新規フラン化合物 |
IT1169783B (it) * | 1983-08-25 | 1987-06-03 | Roussel Maestretti Spa | Derivati dell' acido 4-fenil 4-osso-buten 2-oico, loro procedimento di preparazione e loro applicazione come prodotti medicinali |
US4968817A (en) * | 1984-07-27 | 1990-11-06 | National Distillers And Chemical Corporation | Manufacture of gamma-crotonolactone by carbonylation of glycidol |
DE3920271A1 (de) * | 1989-06-21 | 1991-01-03 | Bayer Ag | N-aryl-stickstoffheterocyclen |
CA2032559C (en) * | 1989-12-28 | 2001-11-06 | Kiyofumi Ishikawa | Endothelin antagonistic cyclic pentapeptides |
EP0524979A4 (en) * | 1990-04-17 | 1993-03-10 | Allergan, Inc. | 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents |
US5183906A (en) * | 1991-04-30 | 1993-02-02 | Allergan, Inc. | 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2 (5h)-furanones as anti-inflammatory agents |
JPH05178706A (ja) * | 1991-12-27 | 1993-07-20 | Sumitomo Chem Co Ltd | 有害節足動物忌避剤 |
AU4547896A (en) * | 1995-02-03 | 1996-08-21 | Banyu Pharmaceutical Co., Ltd. | 4-oxo-2-butenoic acid derivatives |
-
1994
- 1994-08-09 KR KR1019960700841A patent/KR960703901A/ko not_active Application Discontinuation
- 1994-08-09 HU HU9600365A patent/HUT74179A/hu unknown
- 1994-08-09 CZ CZ96409A patent/CZ40996A3/cs unknown
- 1994-08-09 SK SK203-96A patent/SK20396A3/sk unknown
- 1994-08-09 CA CA002165567A patent/CA2165567A1/en not_active Abandoned
- 1994-08-09 JP JP7507074A patent/JPH09501920A/ja active Pending
- 1994-08-09 AU AU75617/94A patent/AU693110B2/en not_active Ceased
- 1994-08-09 EP EP94925831A patent/EP0714391A1/en not_active Withdrawn
- 1994-08-09 WO PCT/US1994/009091 patent/WO1995005376A1/en not_active Application Discontinuation
- 1994-08-09 NZ NZ271833A patent/NZ271833A/xx unknown
-
1995
- 1995-02-06 US US08/384,083 patent/US5691373A/en not_active Expired - Fee Related
-
1996
- 1996-02-14 FI FI960671A patent/FI960671A/fi unknown
- 1996-02-16 NO NO960629A patent/NO960629L/no unknown
-
1997
- 1997-01-22 US US08/787,423 patent/US6017916A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5691373A (en) | 1997-11-25 |
FI960671A (fi) | 1996-04-19 |
CA2165567A1 (en) | 1995-02-23 |
EP0714391A1 (en) | 1996-06-05 |
US6017916A (en) | 2000-01-25 |
HU9600365D0 (en) | 1996-04-29 |
AU7561794A (en) | 1995-03-14 |
FI960671A0 (fi) | 1996-02-14 |
CZ40996A3 (en) | 1996-09-11 |
HUT74179A (en) | 1996-11-28 |
KR960703901A (ko) | 1996-08-31 |
NZ271833A (en) | 1997-08-22 |
AU693110B2 (en) | 1998-06-25 |
SK20396A3 (en) | 1997-03-05 |
JPH09501920A (ja) | 1997-02-25 |
WO1995005376A1 (en) | 1995-02-23 |
NO960629L (no) | 1996-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO960629D0 (no) | (Ikke-peptid endothelin-antagonister I). Substituerte 2 (5H) furanon-,2 (5H) tiofenon- og 2 (5H) pyrrolonderivater, deres fremstilling og deres anvendelse som endetholin-antagonister | |
DK0832082T3 (da) | N-heteroaryl-pyridinsulfonamidderivater og deres anvendelse som endotelinantagonister | |
NO892892L (no) | Substituerte aminometyltetraliner, samt deres heterocykliske analoger. | |
KR960704820A (ko) | 셀프 레벨링 수성 조성물 | |
FI923072A0 (fi) | Maongstegsbindemedel foer anvaendning i elastomerbelaeggningar, mastixbelaeggningar, dikt- och taetningsmedel. | |
NO990544L (no) | Substituerte pyrido- eller pyrimido-inneholdende 6,6 eller 6,7-bycykliske derivater | |
NO943190D0 (no) | Sulfonamid-endothelin-antagonister | |
NO991079D0 (no) | Azinyloksy-og fenoksy-diaryl-karboksylsyre-derivater, deres fremstilling og deres anvendelse som bladete ETA/ETB-endothelin-reseptor-antagonister | |
DK0839146T3 (da) | Piperazinderivater og deres anvendelse som 5-HT1A-antagonister | |
FI962639A (fi) | Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina | |
NO903169D0 (no) | 4,1,2-1h-benzoksadiaziner og deres fremstilling. | |
NO954763D0 (no) | Piperidinderivater, deres fremstilling og anvendelse | |
NO931364L (no) | Tachykinin reseptorantagonister, isokinoloner og deres fremstilling | |
NO972612D0 (no) | Pyridazoner som endotelinreseptorantagonister | |
NO992976D0 (no) | Heterocykliske karboksylsyre-derivater, fremstilling og anvendelse derav som endothelinreseptor-antagonister | |
DK1137644T3 (da) | Benzofuranderivater, deres fremstilling samt anvendelse | |
DK143392A (da) | Skib, isaer handelsskib | |
NO924343L (no) | Substituerte 1,5 pentandioler og deres fremstilling | |
ATE205486T1 (de) | 2,1,3-benzothia(oxa)diazolderivate mit endothelinrezeptor-antagonistischer wirkung | |
NO972822D0 (no) | Fluoralkylglycosiduronsyrer og tilsvarende 6(3)-lactoner, deres fremstilling og anvendelse | |
DK88889D0 (da) | Substituerede imidazolinoner og -thioner, deres fremstilling og anvendelse samt mellemprodukter og disses fremstilling | |
NO20004075D0 (no) | Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister | |
FI923542A0 (fi) | Faestanordning foer klingor, isynnerhet i bestrykningsmaskiner. | |
MX9202291A (es) | Derivados carboxamido-(3,2n)-carbociclico-2-amino tetralinas. | |
NO20000324D0 (no) | Benzotia (oksa) diazolderivater og deres anvendelse som endotelinreseptorantagonister |